Skip to content

CONVERT PHARMACEUTICALS

Active
Public limited companyfounded 2017active for 9 yearsEsplanade Simone VEIL 1, 4000 Liège, Belgium107 active companies are registered at this addressKBO/BCE: BE 0671.828.631
Summary

The computed 12-month bankruptcy probability of CONVERT PHARMACEUTICALS is 1.9% (moderate). The 2025 annual accounts show negative equity (-€841,823) and a net result of -€629,343. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 239 sector peers (NACE 72, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
CONVERT PHARMACEUTICALSActiveChecked score 53/100
Risk analysis ReportCompare

Group and network

Connections & network

4 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

We would like to set cookies. That happens only with your consent. What we measure